Karsten Lindhardt – Biograil™

July 17, 2024November 20, 2024News

Press Release: Biograil and CSL Sign Collaboration Agreement for development of certain CSL compounds using Biograil’s proprietary BIONDD™ technology.

COPENHAGEN, DENMARK, July 17th, 2024 – Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of therapeutics […]

October 4, 2022November 18, 2024News

Press Release: Biograil and Lilly Sign Collaboration and License Agreement

COPENHAGEN, DENMARK, October 4th, 2022 – Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of therapeutics […]

March 14, 2022November 19, 2024News

Press Release: Biograil Receives Innobooster Grant Providing Non-dilutive funding for BIONDD™ in Preparations for Phase 1 clinical trials

COPENHAGEN, DENMARK, 14 March, 2022 – Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of biologics […]

March 1, 2022November 19, 2024News

Press Release: Biograil Forms International Scientific Advisory Board

COPENHAGEN, DENMARK, March 1st, 2022 – Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of biologics […]

February 17, 2022November 20, 2024Uncategorized

Press Release: Biograil Secures Seed 2 Funding for Oral Delivery Device for Biologics

COPENHAGEN, DENMARK, Feb 17th, 2022 – Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of biologics […]

December 2, 2020November 20, 2024News

Press Release: Biograil signs collaboration agreement with Janssen

COPENHAGEN, DENMARK, December 2nd, 2020 – Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of therapeutics […]

April 30, 2020November 20, 2024News

Press Release: Biograil announces – Sanner Ventures has joined Investor Syndicate

COPENHAGEN, DENMARK, April 30, 2020 – Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of biologics […]

April 8, 2020November 18, 2024News

CEO Karsten Lindhardt shares vision for Biograil, by MEGATREND INVEST

January 15, 2020November 20, 2024News

Press Release: Biograil Secures Seed Funding for Oral Delivery Device with Potential to Transform Market for Injectables

COPENHAGEN, DENMARK, January 15, 2020 – Biograil ApS, an innovative biotechnology company developing a unique oral device for delivery of biologics that […]